Truist Securities Initiates Coverage On CareMax with Hold Rating, Announces Price Target of $7.5
Truist Securities analyst Jailendra Singh initiates coverage on CareMax (NASDAQ:CMAX) with a Hold rating and announces Price Target of $7.5.
CareMax Q2 EPS $(0.11) Misses $(0.05) Estimate, Sales $172.30M Beat $136.21M Estimate
CareMax (NASDAQ:CMAX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.05) by 120 percent. This is a 57.69 percent increase over losses of $(0.26) per share from the same
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
CareMax’s Return On Capital Employed Overview
CareMax (NASDAQ:CMAX) brought in sales totaling $136.92 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 849.53%, resulting in a loss of $16.80 million.
62 Biggest Movers From Yesterday
Gainers
Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
